Clearance of atrial natriuretic peptide in patients with cirrhosis: Role of liver failure
- 30 November 1991
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 13 (3) , 351-357
- https://doi.org/10.1016/0168-8278(91)90080-u
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Degradation and clearance of atrial natriuretic factors (ANF)Life Sciences, 1990
- Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.Journal of Clinical Investigation, 1989
- Atrial Natriuretic Factor in Patients with Liver DiseaseAmerican Journal of Nephrology, 1989
- Clearance and early hydrolysis of atrial natriuretic factor in vivo. Structural analysis of cleavage sites and design of an analogue that inhibits hormone cleavage.Journal of Clinical Investigation, 1988
- Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extractionHepatology, 1988
- Atrial natriuretic factor: Possible implications in liver diseaseJournal of Hepatology, 1987
- Circulating atrial natriuretic peptide (ANP) and central blood volume (CBV) in cirrhosisLiver International, 1986
- Atrial natriuretic factor—a circulating hormone stimulated by volume loadingNature, 1985
- Some statistical methods useful in circulation research.Circulation Research, 1980
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973